Coeptis Therapeutics

Wexford, United States

Coeptis Therapeutics is a biopharmaceutical company that focuses on the development and acquisition of cell therapy platforms for patients.

$4.0M raised

Aug 2025

Post-IPO Equity

Biotechnology Health Care Medical Pharmaceutical

Top Investors

CJC

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Coeptis Therapeutics

How much funding has Coeptis Therapeutics raised?

Coeptis Therapeutics has raised $4.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in August 2025.

Who are Coeptis Therapeutics's investors?

Coeptis Therapeutics's investors include CJC.

Where is Coeptis Therapeutics headquartered?

Coeptis Therapeutics is headquartered in Wexford, United States.

What does Coeptis Therapeutics do?

Coeptis Therapeutics is a biopharmaceutical company that focuses on the development and acquisition of cell therapy platforms for patients.

What stage is Coeptis Therapeutics at?

Coeptis Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 6, 2025.

MLA

"Coeptis Therapeutics — Funding & Investors." VCBacked, August 6, 2025, https://www.vcbacked.co/company/coeptis-therapeutics. Accessed July 4, 2026.

APA

VCBacked. (2025). Coeptis Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/coeptis-therapeutics

Wikipedia (cite web)

{{cite web |title=Coeptis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/coeptis-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 6, 2025.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K